GMGabriel Galvão Rafael Magalhães

Gabriel Galvão Rafael Magalhães

*This is an algorithmically generated author record based on publicly available information.

Gabriel Galvão Rafael Magalhães has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience

    by Luciana Pinto Valadares, Bruno Silva de Araújo Ferreira, Bernardo Matos da Cunha, Larissa Aniceto Moreira, Frederico Gideoni Albinati Batista, Cristiane da Fonseca Hottz, Gabriel Galvão Rafael Magalhães

    Objective: Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been used with variable results. Therefore, we aimed to evaluate the effects of zoledronic acid (ZA) therapy in patients with monostotic or polyostotic FD. Subjects and methods: The medical records of thirteen patients with FD evaluated between 2015 and 2020 were retrospectively analyzed. In the subgroup of patients treated with [...] ABSTRACT Objective: Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been used with variable results. Therefore, we aimed to evaluate the effects of zoledronic acid (ZA) therapy in patients with monostotic or polyostotic FD. Subjects and methods: The medical records of thirteen patients with FD evaluated between 2015 and 2020 were retrospectively analyzed. In the subgroup of patients treated with